The Nanomedicine Group at the Instituto de Investigación Valdecilla (IDIVAL) and University of Cantabria, led by Full Professor and Principal Investigator Monica L. Fanarraga, is seeking an outstanding postdoctoral candidate to jointly apply for the Sara Borrell 2026 call. The group is a multidisciplinary team specializing in nanomedicine, molecular and cellular biology, biotechnology, pharmacy, physics, and chemistry. Their research focuses on understanding the interaction of materials with proteins, cells, and tissues to develop advanced products for biomedical applications.

The ideal candidate will have a strong record of high-impact publications (Top 10%) as first or corresponding author, international postdoctoral mobility or long-term research stays, and preferably an Extraordinary Doctorate Award or a European/International PhD mention. The position is open to candidates whose profile aligns with the AES 2026 criteria and who are interested in contributing to innovative research in nanomedicine and biomedical engineering.

The group is based in Santander, Cantabria, Spain, and is recognized for its consolidated expertise and collaborative environment. The successful applicant will work in a dynamic setting, contributing to projects at the intersection of materials science, biology, and medicine. Funding for the position is subject to a successful joint application to the Sara Borrell 2026 call, which typically supports postdoctoral researchers with salary and research expenses.

Interested candidates should contact the group in February 2026 to discuss the application process. For more information about the group and their research, visit their academic page or connect with Prof. Fanarraga on LinkedIn. The application deadline is March 5, 2026, with an expected start date in January 2027 (flexible).

Keywords: nanomedicine, molecular biology, cell biology, biomedical applications, materials science, biotechnology, pharmacy, physics, chemistry.